Pulse Biosciences (PLSE) Retained Earnings (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Retained Earnings of -$463.3 million for Q4 2025, down 18.64% year-over-year from -$569.5 million in Q4 2024, and down 3.91% quarter-over-quarter from -$445.8 million in Q3 2025.
Pulse Biosciences (PLSE) Retained Earnings (2015 - 2026) Analysis & Trends
Pulse Biosciences' Retained Earnings history runs 11 years deep, the most recent figure standing at -$463.3 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 18.64% year-over-year to -$463.3 million; the TTM figure through Dec 2025 stood at -$463.3 million (down 18.64% YoY), while the FY2025 annual figure was -$463.3 million, down 18.64% from the prior year.
- Retained Earnings for Q4 2025 stood at -$463.3 million, down from -$445.8 million in the prior quarter.
- The five-year high for Retained Earnings was -$191.2 million in Q1 2021, with the low at -$463.3 million in Q4 2025.
- The 5-year median for Retained Earnings is -$314.7 million (2023), against an average of -$322.0 million.
- The sharpest annual moves came in 2021 and 2023: Retained Earnings tumbled 1124682.35% in 2021, then slipped 13.83% in 2023.
- Pulse Biosciences' Retained Earnings stood at -$220.8 million in 2021, then slumped by 33.47% to -$294.7 million in 2022, then fell by 10.27% to -$325.0 million in 2023, then fell by 20.16% to -$390.5 million in 2024, then retreated by 18.64% to -$463.3 million in 2025.
- Business Quant data shows PLSE's Retained Earnings at -$463.3 million in Q4 2025, -$445.8 million in Q3 2025, and -$426.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | -506.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -506.52 Mn |
| Dec 31, 2025 | -463.30 Mn |
| Sep 30, 2025 | -445.85 Mn |
| Jun 30, 2025 | -426.46 Mn |
| Dec 31, 2024 | -390.50 Mn |
| Sep 30, 2024 | -371.12 Mn |
| Jun 30, 2024 | -358.44 Mn |
| Mar 31, 2024 | -347.10 Mn |
| Sep 30, 2023 | -324.98 Mn |
| Mar 31, 2023 | -304.51 Mn |
| Dec 31, 2022 | -294.71 Mn |
| Sep 30, 2022 | -285.51 Mn |
| Jun 30, 2022 | -267.50 Mn |
| Mar 31, 2022 | -253.50 Mn |
| Sep 30, 2021 | -220.80 Mn |
| Jun 30, 2021 | -206.50 Mn |
| Mar 31, 2021 | -191.18 Mn |
| Dec 31, 2020 | -172.54 Mn |
| Sep 30, 2020 | -158.80 Mn |
| Jun 30, 2020 | -145.89 Mn |